Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Garrett-Mayer
Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report From the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
Clinical Cancer Research
Cancer Research
Oncology
Efficacy of Adoptive T-Cell Therapy Is Improved by Treatment With the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-Cell Death
Cancer Research
Cancer Research
Oncology
Related publications
Phase 1 Clinical Trial of a New Antiarrhythmic Drug ME3202.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Design of the GutHeart-targeting Gut Microbiota to Treat Heart Failure-Trial: A Phase II, Randomized Clinical Trial
ESC heart failure
Cardiovascular Medicine
Cardiology
Statistical Methods for Survival Trial Design: With Applications to Cancer Clinical Trial Using R
Journal of Biopharmaceutical Statistics
Statistics
Probability
Pharmacology
The Use of Genomics in Clinical Trial Design
Clinical Cancer Research
Cancer Research
Oncology
How to Design a Cell or Gene Therapy Clinical Trial: Advice From the FDA
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
The Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG): Challenges of Study Design
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
OP0105 Long-Term Safety of Tocilizumab From Large Clinical Trial and Postmarketing Populations
Hypothesis Generation and Evaluation in Clinical Trial Design
Lessons Learned From BATTLE-2 in the War on Cancer: The Use of Bayesian Method in Clinical Trial Design
Annals of Translational Medicine
Medicine
